COCP

0.95002.05%
RD

Roger D. Kornberg

Member of Scientific Advisory Board

Prof. Roger D. Kornberg, Ph.D., is Member of Advisory Board of StemRad, Ltd. Prof. Kornberg is a Member of Advisory Board at Bioz, Inc. He is Co-Founder and Co-Chair of Neurodegenerative Scientific & Clinical Advisory Board at Cognos Therapeutics, Inc. from october 2024. He serves as Member of Scientific Advisory Board at Beyond Air, Inc. since November 2024. He serves as Chairman of Science Advisory Board and Director of Neuro-Kinesis Inc. He serves as Member of International Advisory Board at UBQ Materials Ltd. and served as Advisor at Teal-Ventures till 2024. He co-founded Cocrystal Pharma, Inc. in 2008 and serves as its Chief Scientist at Cocrystal Pharma, Inc. since January 2, 2014 and is Director since April 15, 2020 and is Chairman of the Board since May 2021. He had been Member of Scientific Advisory Board at Atomic AI, Inc until 2024. He serves as Member of Scientific Advisory at Sangamo Therapeutics, Inc. since November 2019. He serves as Chairman of Scientific Advisory at Replay Holdings, LLC. He has been the Winzer Professor, Department of Structural Biology and Medicine for Stanford University since 1978. From 1984 to 1992, he served as the Chair of the Department of Structural Biology at Stanford and was Professor of Harvard Medical School. He serves as Chairman of Scientific Advisory Board at Cocrystal Pharma, Inc. He has been Chairman of the Scientific Advisory Board at Niagen Bioscience, Inc. (formerly known as ChromaDex Corporation) since July 8, 2014. He serves as the Head of Scientific Advisory Board at Oplon Ltd. He has been Independent Director of Xenetic Biosciences, Inc. since February 29, 2016. He served as a Director of Gamida Cell Ltd until June 4, 2019. He had been a Director at OphthaliX Inc. (formerly, Denali Concrete Management Inc.) since February 6, 2012 until November 2017. He serves as the Chairman of Scientific Advisory Board at Protalix BioTherapeutics, Inc. He serves as a Member of Scientific Advisory Board at Pacific Biosciences, Inc. (now Pacific Biosciences of California, Inc.) and StemRad, Ltd. He served as a Member of Scientific Advisory Board at Opko Health, Inc. He has been a Member of Scientific Advisory Board at Epiphany Biosciences, Inc. since February 15, 2007. He serves as a Member of Scientific Advisory Board at SuperGen Inc. (now Astex Pharmaceuticals, Inc) and Anchiano Therapeutics Ltd (formerly, BioCancell Ltd. / Anchiano Therapeutics Ltd.). He served as a Member of Advisory Board at Deloitte & Touche LLP. He serves as a Member of Scientific Advisory Board at MDRNA, Inc. (now MDRNA Research, Inc). He served as Scientific Advisory Board Member at Kronos Bio, Inc. since August 2019 until February 2022. He Serves as the Scientific Preseident at Aposense Ltd. and served as a Member of Scientific Advisory Board at Aposense Ltd. since June 23, 2016. He served as a Member of Scientific Advisory Board at Marina Biotech, Inc. He previously served as a Director of Cocrystal Pharma, Inc. since January 2, 2014 until November 22, 2014. Since 1988, he has been a professor of structural biology at Stanford Medical School. He served as an Independent Director of Protalix BioTherapeutics, Inc. since February 7, 2008 until April 12, 2017. He served as a Director of Can-Fite BioPharma Ltd. since February 7, 2012. He served as a Director of Teva Pharmaceutical Industries Limited since July 17, 2007 until 2013. He served as Director of Wize Pharma, Inc. he is a Member of the U.S. National Academy of Sciences, an honorary Member of other academies and professional societies in the United States, Europe and Japan and a fellow of the American Academy of Arts and Sciences. He has been a Member of the faculty of Stanford University since 1972. He was Assistant Professor of Biological Chemistry at Harvard Medical School in 1976. He is an author of over 200 published papers. He was awarded the 2006 Nobel Prize in Chemistry for his seminal studies of the molecular basis of eukaryotic transcription, the biological process by which genetic information from DNA is copied to RNA. His Nobel Prize-winning work included discovery of Mediator, a protein complex required to facilitate gene transcription, as well the solution of the three-dimensional crystal structure of RNA polymerase II, the most complex protein structure solved to date. In 2009, he was elected a Foreign Member of the Royal Society. He was honored for his work with the Eli Lilly Award, the Passano Award, the Ciba-Drew Award, the Gairdner International Award (shared with R. Roeder), the Hoppe-Seyler Lecture Award, the Harvey Prize from the Technion (Israel Institute of Technology), the ASBMB-Merck Award, the Welch Prize in 2001, the Pasarow Award in Cancer Research, the Le Grand Prix Charles-Leopold Mayer in 2002, the 2005 Alfred P. Sloan Jr. Prize and Nobel Prize. He is also the recipient of the 2006 Dickson Prize from University of Pittsburgh and the 2006 Louisa Gross Horwitz Prize from Columbia University. He is a recipient of honorary degrees from universities in Europe and Israel, including the Hebrew University, where he is a Visiting Professor. He is a renowned biochemist. He holds a BA/BS in Chemistry from Harvard University in 1967 and a PhD in Chemical Physics from Stanford University in 1972 and did his postdoctoral studies with Aaron Klug and Francis Crick at the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge (UK) where he discovered the Nucleosome.

Positions